Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine.
about
Dopamine agonists for the treatment of cocaine dependenceDopamine agonists for the treatment of cocaine dependenceAntidepressants for cocaine dependence and problematic cocaine useDopamine agonists for cocaine dependenceAntidepressants for cocaine dependenceDopamine agonists for cocaine dependenceAntidepressants for cocaine dependencePharmacotherapies for cocaine dependencePractical considerations for the clinical use of buprenorphine.Improving the quality of substance dependency treatment with pharmacotherapy.Attention deficit hyperactivity disorder (ADHD) and substance use disorders.New pharmacological approaches for the treatment of alcoholism.Pharmacological treatment of cocaine dependence: a systematic review.Sex effects in cocaine-using methadone patients randomized to contingency management interventions.A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence.Pharmacotherapy of dual substance abuse and dependence.Animal models and treatments for addiction and depression co-morbidity.The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate HomeostasisTreatment of opioid-dependent pregnant women: clinical and research issues.A model for pharmacological research-treatment of cocaine dependence.Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand.Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials.Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.A placebo controlled, double-blind study of mecamylamine treatment for cocaine dependence in patients enrolled in an opiate replacement program.Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence.The treatment of stimulant dependence.Cocaine abuse among methadone maintenance patients: are there effective treatment strategies?Cocaine abuse in methadone maintenance programs: integrating pharmacotherapy with psychosocial interventions.A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909.Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients.Serum prolactin and response to treatment among cocaine-dependent individuals.The significance of a coexisting opioid use disorder in cocaine dependence: an empirical study.Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients.Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management.Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate.Phenytoin in the treatment of cocaine abuse: a double-blind study.Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology.Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer.Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis
P2860
Q24187799-8AA502D6-DA23-4E37-998B-89657B314FC6Q24234240-DEAF90BB-FAF3-474B-B706-1DFC01870488Q24234248-EB0C8114-6FCD-4C60-A8A8-122ADE73B090Q24240089-E04A49C4-7544-419E-BCDF-80CFEE298F1AQ24240094-4AF39AAB-3256-40DF-B787-8EC9CD68AEC1Q24248651-F65130A5-F658-438F-B30A-836E32F4F930Q24248707-F91FEA4B-4F01-482B-B532-C014FB1F02E4Q28174772-362F2160-61F2-4F9E-B1D4-74B1E493716EQ33774853-D6977FC1-FF8A-4D83-9E12-3ABA26421254Q34118712-183C6EA3-67AF-4B27-980A-F33ABF0776E0Q34438018-0896E270-73D6-4366-AC58-7EF8DE1CB725Q34582243-8FC506C6-5742-465E-95D4-E9449FF0C5B5Q34764705-99561AD1-8FF5-4757-8B42-DD3B72919877Q35918605-77D3386B-F1A6-4153-A19C-662B81BA076AQ36642532-372604AE-FB9C-4156-B6F7-E38FC7DBBD71Q36751967-28320112-F2CF-47C0-9C31-8B8E943DCD83Q36797967-757A2B35-039F-412E-BC87-A3E687ACA558Q37062547-8D0FBD08-E582-4703-AD30-7747F9CD5CDCQ37076673-A105DE91-5721-4774-806D-BC2F78370AE2Q37156459-63981D51-55A5-4BA1-B7AA-9BA21F63344DQ37218242-D2F477E6-CB8E-4956-9E43-AC0C2814204EQ37697821-41A47417-AC8B-484F-803D-DC7C657A1FBCQ37702350-5DBB83ED-24A1-448A-BF8A-0BADD2AC62B3Q39754643-E224B4AD-6042-4851-884B-B666AAA34583Q40519636-DC5EB7EF-CA0B-4187-B163-904C7E893C7EQ40583063-78E34CCF-D841-4E95-A429-803CA30A4D4CQ40635736-76BD971E-7CC3-4B74-A635-ABF92A99DAE3Q40635742-193CB311-887A-4D6A-98C0-532B6A582B4EQ40945424-F38D33B4-6A10-489F-AF0A-6F36BDD6A5B3Q40967758-065FE8CB-806B-4F9F-BBBF-8BC301DF92D7Q43921405-98F84049-2D4F-4098-9BBD-C4694148AA1AQ44342150-8608606C-58BE-420B-B058-06929C410EACQ44444200-8208A34E-4814-4CE2-A11C-8C2636A311D0Q44596370-6D4680DA-324D-4D47-A898-A2A77FF0659CQ48501061-7AD14317-E1EE-49BD-B0B2-0945DBC3300CQ51575232-355EF325-726E-4E7A-8369-421B5CD72A89Q51937580-866D5C0F-6F9E-4CD1-BC1F-493D85C2DC45Q53964001-91775346-BD96-4A2F-ACA2-4116609CF4D4Q56481671-489269EC-4B8A-42D0-9547-78EBFEE20688
P2860
Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Pharmacotherapy for cocaine-ab ...... ing amantadine or desipramine.
@en
type
label
Pharmacotherapy for cocaine-ab ...... ing amantadine or desipramine.
@en
prefLabel
Pharmacotherapy for cocaine-ab ...... ing amantadine or desipramine.
@en
P2093
P1433
P1476
Pharmacotherapy for cocaine-ab ...... ing amantadine or desipramine.
@en
P2093
Falcione J
Schottenfeld RS
P304
P356
10.1001/ARCHPSYC.1992.01820110058009
P407
P577
1992-11-01T00:00:00Z